Fig. 3

SMARCB1 protein expression was lost in tumor cells while the nuclear staining was retained in internal control cells (a). Nuclear immunoreactivity to OCT3/4 was observed in a subset of cases, some with strong positivity (b) and others with focal weak staining (c)